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osting by EAbstract Aim: The objective of this study was to investigate the time related proﬁle and efﬁciency
of co-expression of the homeodomain proteins Pdx1, NeuroD, Ngn3, Pax6 and caspase3 with insu-
lin, and to establish the time periods post PDL optimum for islets transplantation.
Study design/methods: In this experimental study, immunoﬂuorescent staining procedure was per-
formed on deparafﬁnized pancreatic duct ligated (PDL) tissues of 78 Sprague–Dawley rats. Quan-
tiﬁcation of protein coexpression was made using a computerized morphometry. The efﬁciency of
co-expression was arbitrary deﬁned by the value of mean ratio (score without unit) of insulin
expression divided by each expression index of the other proteins, occurring within the time interval
of 12–24 h post PDL. Statistical tool was used to analyze the efﬁciency of co-expression of proteins;
analysis of variances (one way ANOVA) was used to compare the means of co-expression indexes
across the time periods pre- and post PDL. P-values less than 0.05 were considered statistically sig-
niﬁcant; no post hoc test was done.
Results: The curve of insulin expression showed a crossover with that of the co-expression at790374141; fax: +27 (0) 866
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D.F. du Toit et al.58different time periods pre- and post PDL. The optimal or higher efﬁciency of co-expression was
observed for insulin and Ngn3 co-expression, while a good or medium efﬁciency was noted for
the co-expression of insulin with Pdx1, insulin with NeuroD and insulin with Pax6. Low or weak
efﬁciency was observed for the co-expression of insulin with caspase3.
Conclusion: We therefore propose an early islets transplantation using 12–24 h post PDL harvested
pancreatic tissues.
 2011 International Journal of Diabetes Mellitus. Published by Elsevier Ltd. All rights reserved.1. Introduction
The mammalian pancreas derives from the foregut endo-
derm. Early differentiation from endodermal cells into endo-
crine cells forming the pancreatic islets of Langerhans is
signiﬁcantly determined by a cascade of genes activation
event [1,2]. During foetal time, the clusters of epithelial cells
in the embryonic phase differentiate into the mature endo-
crine cells of the islets of Langerhans, the duct cells, and
the exocrine cells [3,4].
The chronobiology of these differentiated cells is well
known: the glucagon-expressing alpha cells are followed by
insulin-producing beta cells, somatostatin-producing delta
cells and pancreatic polypeptide-producing PP cells [5,6]. Reli-
able data suggest that protein encoded by some of class B
bHLH genes such as neurogenin 3 (Ngn3) and NeuroD are
interrelated [7], and expressed in an overlapping and redun-
dant manner [8,9]. Ngn3 is required for endocrine fate determi-
nation in the developing mouse pancreas [10]. The proposed
position for the transcription factors Pdx1, Ngn3, Pax6 and
insulin is based on the timing (chronobiology) of individual
protein expression [1,11,12].
As diabetes mellitus (DM) is now a global epidemic, it af-
ﬂicts around 300 million patients worldwide [13], shifting from
developed countries towards developing countries, including
sub-Saharan countries [14]. Studies dealing with pancreas
development at the molecular level are urgently needed. These
studies may be involved in providing cues and potential tools
for in vitro generation of functional beta-cells from stem cells
after the pancreatic duct ligation (PDL), despite existing con-
troversies in post PDL pancreatic atrophy [15], and remark-
able increase in mass of the survived islets [16]. However, the
chronobiology of co-expression of Pdx1, Ngn3, NeuroD and
Pax6 homeodomain proteins is not known, although there
are evident suggestions that transcription factors may be in-
volved in the proliferation of the islet after pancreatic duct
ligation [17,18]. The research question was raised as follows:
what time before 84 h after PDL might be the best moment
to release the duct ligation, or to perform pancreatic transplan-
tation, according to protein co-expression in the rats? Indeed,
the autogenous transplantation of PDL tissue in the kidney of
diabetic rats performed at 84 h following individual expression
of insulin showed a graft failure in 50% of the animal group
[19].
Thus, this study aims to investigate the time-related proﬁle
and efﬁciency of the co-expression of homeodomain proteins
Pdx1, NeuroD, Ngn3, Pax6, and caspase3 with insulin; and
to establish the time periods post PDL optimum for islets
transplantation.2. Materials and methods
2.1. Laboratory animals
Seventy-eight male, randomly selected healthy Sprague–
Dawley rats were obtained from the Central Animal Unit of
the Faculty of Health Sciences, University of Stellenbosch.
The rats were weighed and put into groups of six animals each,
corresponding to the time periods post-PDL of 6, 12, 24, 36,
48, 60, 72, 84, 96, 108 and 120 h, and time periods pre-PDL
of 0 and 5 h at which animals were killed. While animals in
both groups pre-PDL 0 h and 5 h did not undergo duct
ligation, animals in group pre-PDL 5 h had the abdomen
opened and closed only (sham operation).
2.2. Pancreatic duct ligation
A fully equipped microsurgery laboratory at the Department
of Anatomy and Histology was used for the PDL surgical pro-
cedure. A night prior to PDL, the rats were housed in clean
cages and in a thermally controlled environment with free ac-
cess to water but no food.
On the day of the surgical procedure, induction of anaes-
thesia was achieved by 5% halothane vaporized in O2, such
that there was no spontaneous movement and no withdrawal
responses to tail or foot pinch. Abdominal hair was shaved
using a surgical blade, one centimetre on either side of the linea
alba to avoid excessive heat loss. Great care was taken not to
abrade or cut the skin. The shaved portion of the abdominal
surface was then cleaned with betadine antiseptic solution con-
taining providone-iodine at 10 mg/ml (Adcock Ingram Phar-
maceuticals, Industria, Johannesburg, RSA).
The animals were placed on their back (dorsal recum-
bency); the hind limbs were maintained on the surgical table
by means of a paper tape with a minimum tension, to avoid
muscle strains. A mid-line laparotomy incision, starting from
the tip of the xiphoid process to about one centimetre above
the pelvic symphysis, was made to obtain access to the abdom-
inal cavity. The stomach and the duodenum were drawn out
and reﬂected cranially, to expose the pancreas. The topograph-
ical position of the pancreas was noted, and cotton buds were
used to prise the pancreas away from the surrounding tissue. A
Zeiss OPMI-1 operating microscope equipped with a zoom
and a focus adjustment (Carl Zeiss, AG, Oberkochen, Ger-
many) aided in identifying the colourless pancreatic duct. A
resorbable suture material (5/0 sterile white braided silicone
treated polyester, USP, Davis and Geck, Isando, South Africa)
soaked in saline solution, was used for a tight single suture
occluding duct, made at about 1/3 proximal to the tail end
Figure 1 The pancreas of the laboratory rat is prised away to
expose the point of ligation (double bold line) in the splenic lobe.
1 Our study focussed on a number of transcription factors that have
been shown by Schwitzgebel et al. [1] to be involved in endocrine
pancreas development in a speciﬁc time-related pattern.
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damage to the underlying blood vessels.
After ligation, 5 ml of warm saline solution was introduced
into the abdominal cavity, to prevent the post PDL dehydra-
tion. The laparotomy incision was closed in two separate lay-
ers of a continuous (blanket) stitching using 5/0 sterile white
braided silicone treated polyester (Davis and Geck, Isando,
South Africa); ﬁrst the peritoneum together with the abdomi-
nal muscles were sutured and the skin followed thereafter, the
whole procedure taking approximately 10 min. A subcutane-
ous injection of 2.5 mg of Amoxil (Smith-Kline Beecham Phar-
maceuticals, Midrand, RSA) and 0.5 mg streptomycin (Novo-
Strep 5 g/15 ml, Novo Nordish (Pty) Ltd., Johannesburg,
RSA) was administered as a single subcutaneous dose at the
scruff of the neck to guard against infection; the wound was
then swabbed with an antiseptic rub (Beige Pharmaceuticals
Pty. Ltd., Edenvale, South Africa) to minimize scratching.
Animals were returned to clean laboratory rodent cages under
a 60 W lamp necessary for rapid recovery and to counter hypo-
thermia, and were housed in a thermally controlled environ-
ment with free access to water and standard rat chow (Epol,
Midrand, RSA) until they were killed. The effects of the post
procedural treatment regimens, which might impact on the
recapitulation process of endocrine cells development were
not considered and remain an unknown parameter in this
study.
2.3. Tissue removal and processing
On the day of tissue collection corresponding to time periods
pre- and post PDL, animals were anaesthetised as described
earlier; placed in a dorsal recumbence, the hind limbs were
maintained on the surgical table by means of a paper tape,
and a mid-line laparotomy incision was made along the previ-ous incision, to gain access to the abdominal cavity. The stom-
ach and the duodenum were drawn out and reﬂected cranially
to expose the pancreas. The post-ligature portion of the pan-
creas was surgically isolated and removed after the surround-
ing blood vessels had been ligated. The animals were then
euthanized by introducing 200 mg/kg sodium pentobarbitone
into the abdominal cavity and the carcases disposed of by
incineration.
The isolated portions of the pancreas were excised
(5 · 5 mm) and placed in labelled tubes containing Bouin’s ﬂu-
ids for tissue preservation. Approximately 6–18 h later, post-
ligature ﬁxed-portions of the pancreas were placed in labelled
plastic cassettes, and were processed through a standard histol-
ogy routine. The PDL tissues were then embedded in parafﬁn
wax (at 55 C), and the resulting tissue blocks were kept at
room temperature (20–25 C) until sectioning took place.
2.4. Immunochemical markers
The choice for the markers to label the homeodomain proteins
(Pdx1, Ngn3, NeuroD and Pax6) involved in endocrine pan-
creas development was based on the hierarchy in the time re-
lated expressions of the transcription factors.1 The markers
used as primary antibodies were the markers for endocrine
pancreas development genes and cellular apoptosis (caspase-
3) both polyclonal and raised in rabbit, and the monoclonal
marker for Beta cells (insulin) raised in mouse. However, Di-
chloro Triazinyl Amino Fluorescein (FITC) and Cyanine-3
(Cy3) were used as secondary antibodies; both have a dual-
label ﬂuorescent incorporated compound and were goat
anti-Rabbit IgG and goat anti-mouse IgG, respectively. The
markers (primary antibodies and secondary antibodies) were
purchased from CHEMICON International Inc., (Bellerica,
USA).
2.5. Double-label immunoﬂuorescence
Prior to the immunoﬂuorescent procedure, an electric auto-
clave at 1000 W was used to retrieve the antigenicity of tissues
by heating. Plastic racks carrying deparafﬁnised tissue sections
was immersed into the autoclave container ﬁlled with 100 ml
pre-treatment solution of 10 mM citrate buffer (pH 6.0); the
autoclave was switch on until temperate reached 100 C in
about 5 min. Slides were maintained in boiling pre-treatment
solution for further 15 min, when the container was taken
off the autoclave and slides were allowed to cool in the pre-
treatment solution for 20 min at room temperature before
immunostaining took place.
A parallel approach of immunoﬂuorescence dual labeling
(PIFD), was used as follows: Sections were immersed in a
working buffer1 for 3 min and sections were incubated for
30 min with 10 ll of a mixture of the two primary antibodies
(raised from different species, mouse and rabbit) solution at
appropriate respective working dilutions. Sections were rinsed
in working buffer1 for 3 min and subsequently incubated with
10 ll in a mixture of two secondary antibodies FITC and Cy3
at a dilution of 1:200 for 30 min. Sections were washed in
D.F. du Toit et al.600.05% Tween20 in PBS for 3 min and were ﬁnally rinse in dis-
tilled water for 3 min; sections were counterstained and cover
slipped as described earlier. After staining was completed,
slides were stored in dark at 4 C until viewed.
A ﬂuorescent nuclear dye 40,6-diamidino-2-phenylindole
(DAPI) with an antifade solution was used as counterstain
to labelled cell nuclei.2.6. Quantiﬁcation of the co-expression of proteins in PDL
pancreas
The protein expression in tissues were determined by the ﬂuo-
rescence emissions obtained from positive labelled cells; the
resulting images were acquired by the Zeiss colour camera with
the exposure time processed identically under a multidimen-
sional image acquisition module of Axiovision 4.8 (Imaging
System, Carl Zeiss; Mu¨nchen, Germany) driven by a comput-
erized system. The FITC-labelled cells were excited at 490 nm
and emitted green (at 520 nm), while Cy3-labelled cells were
excited at 456 nm and emitted red (562 nm); all counterstained
DAPI-labelled nuclei were excited at 365 nm and emitted blue
(463 nm). The captured images accurately represent the visual
impression of the observer.
The digital images were segmented and the features of the
positive labelled cells were programmed using the automeasur-
ment software of Axiovision 4.8 and MTB2004 conﬁguration
(both Carl Zeiss Vision GmbH). All the images to analyse were
given a name (image name) and the features of measurements
were set as regions and ﬁeld features as described below:
 The regions consisted of each labelled cell (count) and the
area of the individual labelled cell (area).
 The ﬁeld feature consisted of the total number of labelled
cells (total count) expressed n, the total area of labelled cell
(total sum) expressed in lm2 and the expression index.
The number of ﬂuorescent labelled cells for the same antigen
were counted and their cell surface areas measured by automa-
tion. Data were recorded per time post PDL for each immuno-
ﬂuorescence procedure and saved automatically in ﬁles.Figure 2a Dual expression index insulin in blue and caspase3 in
green across the period of times pre- and post-PDL.3. Deﬁnitions
The landmarks in targeting the expression proﬁle of homeodo-
main proteins involved in the remodelling of the pancreas after
surgical duct ligation were determined by the morphological
changes observed under H&E slides of the post ligation por-
tion of the pancreas during the time periods post-pancreatic
ligation (PDL). These landmarks were used in the analysis of
expression patterns of transcription factors following the
quantiﬁcation of protein expressions at each period of time
pre- and post PDL. The resulting expression of individual
homeodomain proteins and their co-expression with insulin
deﬁned the lineage of endocrine cell development in the duct
ligation pancreas in the laboratory rat.
The expression index, which is essentially in quantifying the
protein expression in all the tissue sections in each group, was
calculated using the following formula:
Expression index ¼ total number of count=total areaDual gene expression (co-expression) of different homeodo-
main proteins with insulin was expressed as a ratio of the
expression index of insulin per the expression index of each
one of the proteins across the time period pre- and post
PDL. The co-expression of insulin and other homeodomain
proteins was deﬁned by a curve parallel to the curve of insulin
expression index across the time period pre- and post PDL.
The efﬁciency (highest and earliest expression) of co-expres-
sion was arbitrarily deﬁned by the value of mean ratio (score
without unit) of insulin expression divided by each expression
of the other proteins, occurring within the time interval of 12–
24 h post PDL. Levels of ratio of co-expression were said to be
optimal or high (>25), good or medium (20–25), and low or
weak (>20).
3.1. Ethical issues
Ethical approval was obtained from the University of Stel-
lenbosch Ethics Committee with reference number P04/01/
001. This study complies with the recommendations of the
Declaration and the guiding principles laid down by Animal
Welfare Organization and the Society for the Prevention of
Cruelty to Animals (SPCA).
3.2. Statistical analysis and Immunohistoﬂuorescence evaluation
Continuous variables were expressed as mean ± standard devi-
ation (SD)or standard error ofmean (SEM).To analyse individ-
ual homeodomain protein expression and the efﬁciency of co-
expression of proteins, analysis of variances (one-wayANOVA)
was used to compare the means of protein expression indices
across the different time periods pre- and post-PDL. Simple
coefﬁcient of correlation ‘‘r’’ was calculated to assess potential
associations between the different protein expression indices in
the study. P-values less than 0.05 were considered statistically
signiﬁcant; no post hoc test was done. Data were exported from
MS Excel (Microsoft Inc., USA) to the Statistical Package for
Social Sciences (SPSS) version 15 for Window (SPSS Inc., Chi-
cago, IL, USA) for statistical analysis.
Figure 2b Efﬁciency levels of insulin and caspase3 gene co-
expression across the period of times pre- and post-PDL.
Figure 2c Dual expression index of insulin in blue and Pdx1 in
green across the period of times pre- and post-PDL.
Figure 2d Efﬁciency levels of insulin and Pdx1 co-expression
across the period of times pre- and post-PDL.
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4.1. Co-expression of insulin with caspase3
Fig. 2a shows the mean expression index of insulin and that of
the co-expression (insulin–caspase3) as covariate. The highest
mean expression index of the co-expression occurred between
6 and 24 h post PDL, whereas the highest expression index
of insulin occurred later, at 108 h post PDL.
The efﬁciency curve in Fig. 2b represents the co-expression
index of insulin with caspase3. It shows four modes at 6 h,
24 h, 72 h and 108 h post-PDL. There was a highly statistical
difference (ANOVA; P>0.0001) of its mean values between
all the time periods pre- and post-PDL. The highest mean level
of efﬁciency was 24 h post PDL; however, the variability of
efﬁciency was very high at the same time.
4.2. Co-expression of insulin with Pdx1
The highest mean expression index of insulin was observed at
36 h post PDL, while the highest peaks of the co-expression in-Figure 3a Dual expression index of insulin in blue and Ngn3 in
green across the period of times pre- and post-PDL.
Figure 3b Efﬁciency levels of insulin and Ngn3 co-expression
across the period of times pre- and post-PDL.
Figure 3d Efﬁciency levels of insulin and NeuroD across the
period of times pre- and post-PDL.
Figure 4a Dual expression index of insulin in blue and Pax6 in
green across the period of times pre- and post-PDL.
Figure 4b Efﬁciency levels of insulin and pax6 co-expression
across the period of times pre- and post-PDL.
Figure 3c Dual expression index of insulin in blue and NeuroD
in green across the period of times pre- and post-PDL.
Table 1 Different levels of efﬁciency of proteins co-expressed
with insulin.
Co-expressed
proteins
Means ± SD
of ratio
Times concurrent
with higher ratio (h)
Ins/Casp3 15 ± 2.5 24
Ins/Pdx1 24 ± 11.9 12
Ins/Ngn3 27 ± 18.8 12
Ins/NeuroD 20 ± 26.5 12
Ins/Pax6 20 ± 16.7 24
62 D.F. du Toit et al.dex of insulin with Pdx1 were successively observed at 24 h and
108 h post PDL (Fig. 2c).The efﬁciency level of co-expression of insulin with Pdx1
was characterized by a uni-modal curve with a peak at 36 h
(Fig. 2d). This peak was deﬁned by higher variability. There
was a signiﬁcant difference (ANOVA; P> 0.0001) between
all the times periods pre- and post PDL.
4.3. Co-expression of insulin with Ngn3
The highest mean levels of expression index of insulin occurred
between 72 h and 84 h post PDL, whereas the highest peaks of
co-expression of insulin with Ngn3 were successively observed
at 12 h and 120 h post PDL (Fig. 3a).
Fig. 3b depicts the mean efﬁciency levels of insulin and
Ngn3 co-expression. The highest level of efﬁciency was concur-
rent, at 12 h. A signiﬁcant difference (ANOVA; P> 0.0001)
was observed between the time periods post-PDL.
4.4. Co-expression of insulin with NeuroD
The curve of co-expression index of insulin and NeuroD was
dominant in comparison with that of insulin expression at
the time periods 0 and 6 h and later between 60 and 84 h with
an overshoot observed at 72 h post PDL. This contrasted with
the plateau mode of insulin expression between 60 h and 84 h
post PDL (Fig. 3c).
However, the mean efﬁciency levels of insulin and NeuroD
co-expression reached a highest peak at 12 h (Fig. 3d). A high-
er variability of efﬁciency was observed at 6–24 h. There was a
Efﬁciency of co-expression of transcription factors Pdx1, Ngn3, NeuroD and Pax6 with insulin: A statistical approach 63signiﬁcant difference (ANOVA; P= 0.007) of efﬁciency mean
values between the time periods pre- and post-PDL.
4.5. Co-expression of insulin with Pax6
The highest mean of the co-expression index of insulin and
Pax6 was observed at 12 h post PDL, whereas the expression
of insulin was totally dominant over that of the co-expression
with a plateau mode between 36 h and 84 h (Fig. 4a).
The mean efﬁciency levels of insulin and Pax6 co-expression
reached a highest peak at 24 h (Fig. 4b). There was a signiﬁ-
cant difference (ANOVA; P> 0.0001) of mean values be-
tween the time periods post-PDL.
4.6. Comparison of efﬁciency levels in protein co-expression
Table 1 compares the levels of efﬁciency for the various
homeodomain protein co-expressions with insulin. There was
a signiﬁcant difference of efﬁciency levels across the proteins
involved in the study (ANOVA; P< 0.05).
The optimal or high efﬁciency of co-expression was ob-
served for insulin and Ngn3 co-expression, while a good or
medium efﬁciency was for the co-expression of insulin with
Pdx1, insulin with NeuroD and insulin with Pax6. Weak or
low efﬁciency was observed for insulin and caspase3 co-
expression.
5. Discussion
The present study assessed the dual expression of various
homeodomain proteins implicated in the endocrine pancreas
development during the time periods post PDL. Thus, the pro-
ﬁle, the variations, the intercorrelations and the efﬁciency of
insulin, caspase3, Pdx1, Ngn3, NeuroD and Pax6 were investi-
gated in PDL model of laboratory rats. This was necessary to
understand the chronobiology of expression of these proteins
in order to determine the optimum time periods for islets
transplantation.5.1. Insulin expression and its variations when co-expressed with
other proteins
The highest expression of insulin in this study was observed at
84 h post PDL; the same time was observed in the immunoﬂu-
orescent evaluation. There was a signiﬁcant and positive corre-
lation between Ngn3, Pax6 and insulin expression. This is
logical as insulin expression requires a mature endocrine beta
cell development [1]. Previously, it was revealed that early insu-
lin-expressing cells have low insulin levels [20] and these cells
do not co-express transcription factor Pdx1 [21,22]. This is
demonstrated by the low levels of insulin expression in the ﬁrst
mode of the insulin expression curve in this study.
When insulin was expressed at the same time with the other
assessed, the efﬁciency of co-expression was observed between
insulin and Ngn3 (optimal or high efﬁciency); insulin with
Pdx1, insulin with NeuroD and insulin with Pax6 (good or
medium efﬁciency) and insulin with caspase3 (low or weak efﬁ-
ciency). Indeed the highest efﬁciency of co-expression of insu-
lin with Pdx1, Ngn3 and NeuroD occurred at 12 h post PDL.
These ﬁndings conﬁrmed the dependency of the islet of Lan-gerhans development on the sequential cascade of transcrip-
tion factors activation phases [2]. The highest efﬁciency of
co-expression of insulin with Pax6 occurred differently at
24 h, and probably may be due to the extent and span of
Pax6 function throughout the endocrine development until
the endocrine cells reach maturity [4,11,23,24].
Furthermore, the morphological changes observed in the
pancreas during differentiation process may also be dependent
on sequential alteration in transcription factors [25–31]. The
highest co-expression of Ngn3, Pdx1 and NeuroD with insulin
at early stage of endocrine cell lineage in PDL pancreas is in
agreement with many studies [2,10,32–34]. However, this study
further enlightens previous suggestion that duct ligated pancre-
atic tissues obtained at 84 h post PDL and used for transplan-
tation yielded 50% success rate [17]. We therefore propose an
early transplantation using 12–24 h post PDL harvested pan-
creatic tissues. This suggestion has not been reported in
literature.
5.2. Implications and perspectives of the study
The present data on beta cell development and co-expression
of insulin with caspase3, Pdx1, Ngn3, NeuroD and pax6 will
have implications in the pathophysiology of the pancreas, such
as diabetes mellitus management.
5.3. Strength and limitations of the study
The present study may be limited to some degree, despite its
strength from rigourous methodology. Its strength resides in
the use of pre- and post PDL tissues preserved in Bouin’s ﬂuid
for immunohistoﬂuorescent study not commonly used else-
where; and which may also be its ﬁrst limitation.
The second limitation was the lack of optimization and
method controls omitted in the materials and methods, which
could have helped in reducing some false positive results of
gene expression. This might well serve to explain the higher
variability (systematic error or bias in measurement) of gene
expression at critical times.
The strength of the study is based on the use of the expres-
sion pattern of transcription factors and the deﬁnition of the
time-related efﬁciency of the expression of each protein proﬁle
according to the sequence of cellular lineage after PDL. This
approach helped to categorize the present result in morpholog-
ical changes as landmarks for each target protein expression.
While this study reinforces the observation from the litera-
ture [35] that showed that the activation of beta cell progeni-
tors and increased beta cell mass in adult mice pancreas
following ductal ligation, it is important highlight some limita-
tions regarding total caspase3 expression and sophisticated
and expensive techniques.
Total caspase3 expression is not generally an accepted mea-
sure of cell death. The lack of cleaved caspase3 and/or TUN-
EL staining markers of both necrosis and apoptosis, forced us
to use total caspase2 expression to evaluate beta-cell death.
Beta cell proliferation was not evaluated using Ki67, PCNA
or PH3 expression.
Co-expression of glucagon plus insulin was not quantiﬁed
in this study, this be performed in future as extreme beta cell
loss results in conversion of adult pancreatic alpha-cells to
beta-cells [36].
D.F. du Toit et al.646. Conclusion
These ﬁndings indicate that the optimal efﬁciency of co-expres-
sion of insulin with each one of the assessed homeodomain
proteins occur between 12 h and 24 h after PDL. We therefore
propose an early islets transplantation, using 12–24 h post
PDL harvested pancreatic tissues.
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